Aer Therapeutics

Durham, United Kingdom · Founded 2014 · Privately Held (backing)

Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. Aer Therapeutics is based in Durham, United Kingdom and was founded in 2014. It was valued at $58 million at a debt round in Mar 2025, the last priced event on record. It has raised $48 million across 2 recorded rounds; the latest was a $5 million early-stage round in Jan 2025.

PMV mark · valuation
$58.0M
Oct 2026
Priced at
a debt round
Mar 2025
Total raised
$48.0M
Last round
Early Stage VC
Jan 2025
How much has Aer Therapeutics raised?
$48.0Macross 2 recorded rounds · Dec 2022 – Jan 2025

Most recently, Aer Therapeutics raised $5.0M in its Early Stage VC (Jan 2025).

Free account
More of Aer Therapeutics with a free account
  • ·Watch Aer Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Aer Therapeutics round by round

2 rounds
Jan 2025Early Stage VC$5.0MSEC filing▮
15 investors participated
Dec 2022Early Stage VC$15.9MSEC filing▮
23 investors participated

How much has Aer Therapeutics raised?

Aer Therapeutics has raised $48 million in total; 2 of its rounds are on record. The largest on record was a $5 million early-stage round in Jan 2025.

Aer Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Feb 2025 ($5 million sold to 15 investors).

Aer Therapeutics investors

6 investors are on record for Aer Therapeutics, including National Institutes of Health, OrbiMed, Canaan Partners and Hatteras Venture Partners. The early-stage round in Jan 2025 drew 15 investors.

For fundraisers
Raising for a company like Aer Therapeutics?

6 investors have backed Aer Therapeutics.

See all 6 investors →

Frequently asked about Aer Therapeutics

How much has Aer Therapeutics raised?
Aer Therapeutics has raised $48.0M in total across 2 recorded funding rounds.
When was Aer Therapeutics's last funding round?
Aer Therapeutics's most recent recorded round was Early Stage VC in Jan 2025, raising $5.0M.